Plerixafor Injection
Product Images NDC 70710-1208

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Plerixafor (NDC 70710-1208). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (1304ddb2 6938 42af Aa4a 3eed8b151ae8 01)

Chemical structure diagram of plerixafor, showing the molecular framework with two macrocyclic rings connected by a benzene ring.*

FDA Label Image

Container Label (1304ddb2 6938 42af Aa4a 3eed8b151ae8 02)

Label for Plerixafor Injection 24 mg/1.2 mL (20 mg/mL) in a single-dose vial. Distributed by Zydus Pharmaceuticals USA Inc., made in India. The label includes a barcode, dosing form as subcutaneous injection, a statement about natural rubber latex, lot and expiration details, and the NDC 70710-1208-1.*

FDA Label Image

Carton Label (1304ddb2 6938 42af Aa4a 3eed8b151ae8 03)

Packaging label for PLERIXAFOR Injection 24 mg/1.2 mL (20 mg/mL) by Zydus Pharmaceuticals USA Inc. The label indicates it is for subcutaneous injection only, contains one single dose vial, and instructs to discard the unused portion. The label includes dosage concentration, NDC 70710-1208-1, and manufacturer details. It features standard regulatory and storage text along with barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.